Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T Tran

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Gene|February 28, 1997
Molecular cloning of the human methylthioadenosine phosphorylase processed pseudogene and localization to 3q28P T Tran, H Hori, Y Hori, et al.
Bioconjugate Chemistry|July 19, 2001
Synthesis and characterization of a ruthenium(II)-based redox conjugate for reagentless biosensingS A Trammell, H M Goldston, P T Tran, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesS P Rowe, M A Gorin, M E Allaf, et al.
Medical Oncology (Northwood, London, England)|June 12, 2020
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.
The American Journal of Medicine|August 1, 1994
The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findingsB Cochand-Priollet, P J Guillausseau, S Chagnon, et al.
Prostate Cancer and Prostatic Diseases|January 4, 2017
Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, et al.
Current Molecular Medicine|February 2, 2012
Tissue biomarkers for prostate cancer radiation therapyP T Tran, R K Hales, J Zeng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2017
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerA K Narang, J Trieu, N Radwan, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomyA J Armstrong, S Halabi, P Healy, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Gene|February 28, 1997
Molecular cloning of the human methylthioadenosine phosphorylase processed pseudogene and localization to 3q28P T Tran, H Hori, Y Hori, et al.
Bioconjugate Chemistry|July 19, 2001
Synthesis and characterization of a ruthenium(II)-based redox conjugate for reagentless biosensingS A Trammell, H M Goldston, P T Tran, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challengesS P Rowe, M A Gorin, M E Allaf, et al.
Medical Oncology (Northwood, London, England)|June 12, 2020
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.
The American Journal of Medicine|August 1, 1994
The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findingsB Cochand-Priollet, P J Guillausseau, S Chagnon, et al.
Prostate Cancer and Prostatic Diseases|January 4, 2017
Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive diseaseJ J Tosoian, R Alam, C Gergis, et al.
Current Molecular Medicine|February 2, 2012
Tissue biomarkers for prostate cancer radiation therapyP T Tran, R K Hales, J Zeng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2017
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerA K Narang, J Trieu, N Radwan, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2016
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomyA J Armstrong, S Halabi, P Healy, et al.
Pageof 5